Effects of Rosiglitazone on Neointimal Formation in Rabbits
Author Information
Author(s): Alessi Alexandre, França Neto Olímpio Ribeiro, Brofman Paulo Roberto Slud, Prim Camila, Noronha Lucia, Silva Ruy Fernando Kuenzer Caetano, Baroncini Liz Andréa Villela, Précoma Dalton Bertolim
Primary Institution: Center of Health and Biological Sciences, Pontifical Catholic University of Paraná, Brazil
Hypothesis
Does rosiglitazone administered at different times affect neointimal formation in hypercholesterolemic rabbits following vascular injury?
Conclusion
Pretreatment with rosiglitazone in hypercholesterolemic rabbits submitted to vascular injury significantly reduces neointimal formation.
Supporting Evidence
- Intimal area was significantly lower in group II compared to the control group.
- Luminal layer area was higher in group II compared to both control and group I.
- There was a significant reduction of 65% and 71% in intima/media layer area ratio in group II compared to control and group I.
Takeaway
Giving a medicine called rosiglitazone to rabbits before they get hurt helps their blood vessels heal better and grow less scar tissue.
Methodology
Thirty-nine hypercholesterolemic rabbits were divided into three groups: control, post-injury treatment, and continuous treatment, with histological analysis performed post-surgery.
Potential Biases
None reported.
Limitations
The evaluation period was short, and the effects observed may be due to chance.
Participant Demographics
Thirty-nine white adult male New Zealand rabbits.
Statistical Information
P-Value
p = 0.024, p = 0.006, p < 0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website